Yüklüyor......
Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette–Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer
A significant number of patients with intermediate- or high-risk bladder cancer treated with intravesical Bacillus Calmette–Guérin (BCG) immunotherapy are non-responders to this treatment. Since we cannot predict in which patients BCG therapy will fail, markers for responders are needed. UroVysion(®...
Kaydedildi:
| Yayımlandı: | Med Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer US
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5581817/ https://ncbi.nlm.nih.gov/pubmed/28866819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-017-1033-z |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|